Joseph Rosenecker - Nanotechnology

Author Information

Joseph Rosenecker is affiliated with the Department of Pediatrics at Ludwig Maximilian University of Munich, located in Munich, Germany. His research largely focuses on the application of nanotechnologies for the delivery of DNA and mRNA vaccines, as well as gene therapy approaches, particularly targeting diseases such as cystic fibrosis and Alpha-1-Antitrypsin Deficiency.

Research Contributions

Joseph Rosenecker has made significant contributions to the field of nanotechnology, particularly in the development and optimization of mRNA and DNA delivery systems for therapeutic purposes. His research includes innovative approaches for treating genetic diseases such as cystic fibrosis and Alpha-1-Antitrypsin Deficiency through nonviral vector-based delivery systems and topical application of in vitro transcribed mRNA. His work also extends to the investigation of glucose tolerance in patients with cystic fibrosis and the treatment of lung disease in STAT3 hyper-IgE syndrome.

Aliases

J Rosenecker, J. Rosenecker, Joseph Rosenecker, Josef Rosenecker

Publication and Citation Metrics

Metric	Value
Citation Count	4197
H-Index	30
Paper Count	66

Publications:

Nanotechnologies in Delivery of DNA and mRNA Vaccines to the Nasal and Pulmonary Mucosa

DOI: 10.3390/nano12020226

Year: 2022

In Vitro Investigations on Optimizing and Nebulization of IVT-mRNA Formulations for Potential Pulmonary Based Alpha-1-Antitrypsin Deficiency Treatment

DOI: 10.21203/rs.3.rs-133486/v1

Year: 2021

In Vitro Investigations on Optimizing and Nebulization of IVT-mRNA Formulations for Potential Pulmonary-Based Alpha-1-Antitrypsin Deficiency Treatment

DOI: 10.3390/pharmaceutics13081281

Year: 2021

Glucose Tolerance in Patients with Cystic Fibrosis - Results from the German Cystic Fibrosis Registry.

DOI: 10.1055/a-1117-3771

Year: 2020

Self-assembled peptide–poloxamine nanoparticles enable in vitro and in vivo genome restoration for cystic fibrosis

DOI: 10.1038/s41565-018-0358-x

Year: 2019

Lung disease in STAT3 hyper‐IgE syndrome requires intense therapy

DOI: 10.1111/all.13753

Year: 2019

Which role does homeopathy play in the project “Integrative Pediatrics” at three children's hospitals in Germany?

DOI: 10.1055/S-0037-1601142

Year: 2017

Homeopathy in children with Prader-Willi-Syndrome, a genetic disease

DOI: 10.1055/S-0037-1601143

Year: 2017

Nanotechnologies in delivery of mRNA therapeutics using nonviral vector-based delivery systems

DOI: 10.1038/gt.2017.5

Year: 2017

Topical Application of In Vitro Transcribed mRNA to the Airways as a Novel Gene Therapy Approach for the Treatment of Cystic Fibrosis

DOI: 10.2174/2212707004666170502170037

Year: 2017

What is Micro Raman Spectroscopy?

How Does Nanotechnology Reduce Material Waste?

How Can Public Engagement be Fostered?

How to Address Ethical Considerations?

2. How can policies ensure privacy?

What are Public Repositories in Nanotechnology?

How is k-Means Applied in Nanotechnology?

How Does Nanotechnology Enhance Smart Curtains?

What are Some Examples of Customizable Nanomaterials?

What Are the Core Components of Nanotechnology Training Programs?

Partnered Content Networks

Relevant Topics